President Donald Trump returned to office determined to lower prices, bring manufacturing back to the United States, and unleash American innovation.
His policies are already producing results. Pharmaceutical companies have announced roughly $500 billion in new American investments in research, manufacturing, and infrastructure. President Trump has also challenged the foreign governments that have been paying artificially low prices for American medicines and leaving American patients to finance much of the world’s medical research.